Hilsenbeck S - Search Results

1

Prognostic factors of early stage cervical cancer treated by radical hysterectomy.

Sevin BU, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli OR, Averette HE. Sevin BU, et al. Among authors: hilsenbeck s. Cancer. 1995 Nov 15;76(10 Suppl):1978-86. doi: 10.1002/1097-0142(19951115)76:10+<1978::aid-cncr2820761313>3.0.co;2-k. Cancer. 1995. PMID: 8634988

2

Microinvasive carcinoma of the cervix.

Sevin BU, Nadji M, Averette HE, Hilsenbeck S, Smith D, Lampe B. Sevin BU, et al. Among authors: hilsenbeck s. Cancer. 1992 Oct 15;70(8):2121-8. doi: 10.1002/1097-0142(19921015)70:8<2121::aid-cncr2820700819>3.0.co;2-s. Cancer. 1992. PMID: 1394041 Review.

3

The prognostic significance of surgical staging for carcinoma of the endometrium.

Wolfson AH, Sightler SE, Markoe AM, Schwade JG, Averette HE, Ganjei P, Hilsenbeck SG. Wolfson AH, et al. Among authors: hilsenbeck sg. Gynecol Oncol. 1992 May;45(2):142-6. doi: 10.1016/0090-8258(92)90276-o. Gynecol Oncol. 1992. PMID: 1592280

4

Survival after first recurrence of breast cancer. The Miami experience.

Vogel CL, Azevedo S, Hilsenbeck S, East DR, Ayub J. Vogel CL, et al. Among authors: hilsenbeck s. Cancer. 1992 Jul 1;70(1):129-35. doi: 10.1002/1097-0142(19920701)70:1<129::aid-cncr2820700122>3.0.co;2-y. Cancer. 1992. PMID: 1606535 Review.

5

Long-term survival in stage III and IV ovarian cancer.

Petru E, Sevin BU, Averette HE, Koechli OR, Hilsenbeck S. Petru E, et al. Among authors: hilsenbeck s. Arch Gynecol Obstet. 1991;249(2):87-93. doi: 10.1007/BF02390367. Arch Gynecol Obstet. 1991. PMID: 1953056

6

Comparative efficacy of short-term versus long-term cefoxitin prophylaxis against postoperative infection after radical hysterectomy: a prospective study.

Sevin BU, Ramos R, Gerhardt RT, Guerra L, Hilsenbeck S, Averette HE. Sevin BU, et al. Among authors: hilsenbeck s. Obstet Gynecol. 1991 May;77(5):729-34. Obstet Gynecol. 1991. PMID: 2014087 Clinical Trial.

7

Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line.

Boike GM, Petru E, Sevin BU, Averette HE, Chou TC, Penalver M, Donato D, Schiano M, Hilsenbeck SG, Perras J. Boike GM, et al. Among authors: hilsenbeck sg. Gynecol Oncol. 1990 Sep;38(3):315-22. doi: 10.1016/0090-8258(90)90065-s. Gynecol Oncol. 1990. PMID: 2121626 Free article.

8

Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.

Petru E, Sevin BU, Averette HE, Koechli OR, Perras JP, Hilsenbeck S. Petru E, et al. Among authors: hilsenbeck s. Gynecol Oncol. 1990 Aug;38(2):181-6. doi: 10.1016/0090-8258(90)90037-l. Gynecol Oncol. 1990. PMID: 2387533 Free article.

9

Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature.

Davila E, Vogel CL, East D, Cairns V, Hilsenbeck S. Davila E, et al. Among authors: hilsenbeck s. Cancer. 1988 Jun 1;61(11):2161-7. doi: 10.1002/1097-0142(19880601)61:11<2161::aid-cncr2820611105>3.0.co;2-2. Cancer. 1988. PMID: 2966667

10

Prognostic factors in lung cancer based on multivariate analysis.

Hilsenbeck SG, Raub WA Jr, Sridhar KS. Hilsenbeck SG, et al. Am J Clin Oncol. 1993 Aug;16(4):301-9. doi: 10.1097/00000421-199308000-00005. Am J Clin Oncol. 1993. PMID: 8328408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters